Jim Simons Kaleido Biosciences, Inc. Transaction History

Renaissance Technologies LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.05 - $1.7 $4,344 - $147,707	-86,887 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$1.3 - $2.7 $61,766 - $128,285	47,513 Added 120.67%	86,887 $143,000
Q4 2021 Feb 11, 2022	BUY	$2.39 - $6.02 $22,881 - $57,635	9,574 Added 32.13%	39,374 $94,000
Q3 2021 Nov 12, 2021	BUY	$5.36 - $7.99 $159,728 - $238,102	29,800 New	29,800 $163,000
Q2 2021 Aug 13, 2021	SELL	$5.82 - $8.72 $314,862 - $471,752	-54,100 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$7.2 - $16.82 $389,520 - $909,962	54,100 New	54,100 $438,000

2.65K

Ticker KLDO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,622,600
Description
Kaleido Biosciences, Inc., a clinical-stage healthcare company, develops microbiome metabolic therapies. The company develops KB195 for the treatment of patients with urea cycle disorder; KB295 to treat ulcerative colitis; KB174 for the treatment of hepatic encephalopathy; and KB109 to treat COVID-19 disease. It also develops programs for the tr...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.